Healthcare provider profile · identity verified

Bijoya Goswami

Internal Medicine · JAMAICA, NY · NPI 1013308931

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	367	124
Amlodipine Besylate	Amlodipine Besylate	336	103
Levothyroxine Sodium	Levothyroxine Sodium	274	70
Losartan Potassium	Losartan Potassium	259	80
Metoprolol Succinate	Metoprolol Succinate	190	61
Lisinopril	Lisinopril	173	50
Omeprazole	Omeprazole	173	55
Hydrochlorothiazide	Hydrochlorothiazide	161	48
Rosuvastatin Calcium	Rosuvastatin Calcium	138	38
Furosemide	Furosemide	136	45
Metformin Hcl	Metformin Hcl	136	43
Sertraline Hcl	Sertraline Hcl	118	38
Metoprolol Tartrate	Metoprolol Tartrate	103	26
Simvastatin	Simvastatin	97	26
Pantoprazole Sodium	Pantoprazole Sodium	93	29
Trazodone Hcl	Trazodone Hcl	93	31
Gabapentin	Gabapentin	91	33
Tamsulosin Hcl	Tamsulosin Hcl	91	25
Pravastatin Sodium	Pravastatin Sodium	81	22
Fluticasone Propionate	Fluticasone Propionate	76	28
Albuterol Sulfate Hfa	Albuterol Sulfate	72	43
Synthroid	Levothyroxine Sodium	71	20
Montelukast Sodium	Montelukast Sodium	69	21
Potassium Chloride	Potassium Chloride	65	21
Carvedilol	Carvedilol	60	17
Glipizide Er	Glipizide	56	19
Clopidogrel	Clopidogrel Bisulfate	55	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	15
Tramadol Hcl	Tramadol Hcl	49	12
Citalopram Hbr	Citalopram Hydrobromide	48	13
Doxazosin Mesylate	Doxazosin Mesylate	48	14
Lovastatin	Lovastatin	48	11
Duloxetine Hcl	Duloxetine Hcl	47	18
Alendronate Sodium	Alendronate Sodium	46	16
Famotidine	Famotidine	46	17
Ezetimibe	Ezetimibe	45	16
Spironolactone	Spironolactone	45	14
Zolpidem Tartrate	Zolpidem Tartrate	43	12
Venlafaxine Hcl Er	Venlafaxine Hcl	42	12
Lorazepam	Lorazepam	40	suppressed
Eliquis	Apixaban	39	11
Hydralazine Hcl	Hydralazine Hcl	39	15
Allopurinol	Allopurinol	38	11
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	14
Ozempic	Semaglutide	37	11
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	14
Metformin Hcl Er	Metformin Hcl	33	14
Farxiga	Dapagliflozin Propanediol	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Prednisone	Prednisone	32	25
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	11
Alprazolam	Alprazolam	30	suppressed
Finasteride	Finasteride	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	14
Glipizide	Glipizide	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	11
Xarelto	Rivaroxaban	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Felodipine Er	Felodipine	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Glimepiride	Glimepiride	22	suppressed
Atenolol	Atenolol	21	suppressed
Bumetanide	Bumetanide	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Acyclovir	Acyclovir	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Diazepam	Diazepam	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Azithromycin	Azithromycin	19	16
Buspirone Hcl	Buspirone Hcl	19	suppressed
Cephalexin	Cephalexin	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Tradjenta	Linagliptin	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Valsartan	Valsartan	13	suppressed
Baclofen	Baclofen	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Toprol Xl	Metoprolol Succinate	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Lansoprazole	Lansoprazole	11	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed
Topiramate	Topiramate	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error